Shopping Cart 0
Cart Subtotal
USD 0

SeraCare Life Sciences, Inc. - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

SeraCare Life Sciences, Inc. (SeraCare) carries out the discovery, development, manufacture and supply of disease-state specimens and tissues for research and development, processed biological materials, immunoassay reagents and quality control products and technologies. Its major products include next-gen sequencing and digital PCR tools, controls and reference materials, validation and lot qualification materials; plasma and serum diluents/derivatives; cell culture reagents; antibodies and conjugates; and immunoassay reagents and kits. SeraCare's major customers include IVD manufacturers; government and regulatory agencies; and pharmaceutical and biotechnology companies; veterinary companies; and academic and government research organizations. It has facilities in Milford, Massachusetts and Gaithersburg, Maryland. The company distributes its products through a network of distributors in several countries the world over. SeraCare is headquartered in Milford, Massachusetts, the US.

SeraCare Life Sciences, Inc.-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

SeraCare Life Sciences, Inc., Medical Equipment, Deals By Year, 2012 to YTD 2018 5

SeraCare Life Sciences, Inc., Medical Equipment Deals By Type, 2012 to YTD 2018 6

SeraCare Life Sciences, Inc., Medical Equipment, Deals By Region, 2012 to YTD 2018 7

SeraCare Life Sciences, Inc., Medical Equipment, Deals By Market, 2012 to YTD 2018 8

SeraCare Life Sciences, Inc., Medical Equipment, Deals Summary, 2012 to YTD 2018 9

SeraCare Life Sciences, Inc., Medical Equipment, Deal Details 10

Private Equity 10

SeraCare Receives Shareholders Approval For Its Acquisition By Linden Capital For USD 82 Million 10

Partnerships 12

SeraCare Life Sciences Enters into Agreement with ArcherDx 12

SeraCare Life Sciences Enters into R&D Agreement with National Institute of Standards and Technology 13

SeraCare Life Sciences Forms Partnership with Toma Biosciences 14

Swift Biosciences Partners with SeraCare Life Sciences 15

SeraCare Life Sciences Enters into Co-Marketing Agreement with ViveBio 16

SeraCare Life Sciences Enters into R&D Agreement with National Cancer Institute 17

Acquisition 18

SeraCare Life Sciences Acquires Kirkegaard & Perry Labs 18

SeraCare Life Sciences, Inc.-Key Competitors 19

SeraCare Life Sciences, Inc.-Key Employees 20

SeraCare Life Sciences, Inc.-Locations And Subsidiaries 21

Head Office 21

Other Locations & Subsidiaries 21

Recent Developments 22

Corporate Communications 22

Jan 08, 2018: SeraCare Life Sciences Announces Joe Bernardo as New Company Chairman 22

Product News 23

Apr 16, 2018: SeraCare Announces Expansion of Industry's Most Complete and Patient-Like ctDNA Reference Materials 23

Aug 01, 2017: SeraCare Announces the Launch of a Suite of Zika Virus Reference Materials for Improved Diagnostic Testing 24

Jul 18, 2017: SeraCare Life Sciences Announces the Most Patient-Like cfDNA QC Technology 25

Mar 23, 2017: SeraCare Life Sciences announces launch of industry's first multiplexed Inherited Cancer reference material 26

Feb 21, 2017: SeraCare Life Sciences Announces New Highly Multiplexed Fusion RNA Assay Reference Standards 27

Feb 08, 2017: SeraCare Life Sciences Announces Presentation on Enabling Clinical Genomics with Highly Multiplexed Reference Materials 28

Other Significant Developments 29

Feb 13, 2018: SeraCare Announces Industry's First CNV-Specific Reference Material for Gene Amplifications in Breast, Lung, and Brain Cancer 29

Nov 08, 2017: SeraCare Announces Industry's First Comprehensive NGS Reference Material for Hematologic Malignancies 30

Appendix 31

Methodology 31

About GlobalData 31

Contact Us 31

Disclaimer 31


List Of Figure

List of Figures

SeraCare Life Sciences, Inc., Medical Equipment, Deals by Type, 2012 to YTD 2018 2

SeraCare Life Sciences, Inc., Medical Equipment, Deals By Year, 2012 to YTD 2018 2

SeraCare Life Sciences, Inc., Medical Equipment, Deals By Region, 2012 to YTD 2018 2

SeraCare Life Sciences, Inc., Medical Equipment, Deals By Market, 2012 to YTD 2018 2

SeraCare Life Sciences, Inc., Medical Equipment, Deals By Year, 2012 to YTD 2018 5

SeraCare Life Sciences, Inc., Medical Equipment, Deals by Type, 2012 to YTD 2018 6

SeraCare Life Sciences, Inc., Medical Equipment, Deals By Region, 2012 to YTD 2018 7

SeraCare Life Sciences, Inc., Medical Equipment, Deals by Market, 2012 to YTD 2018 8


List Of Table

List of Tables

SeraCare Life Sciences, Inc., Medical Equipment, Key Facts 2

SeraCare Life Sciences, Inc., Medical Equipment, Deals Summary, 2012 to YTD 2018 2

SeraCare Life Sciences, Inc., Medical Equipment, Deals By Year, 2012 to YTD 2018 5

SeraCare Life Sciences, Inc., Medical Equipment Deals By Type, 2012 to YTD 2018 6

SeraCare Life Sciences, Inc., Medical Equipment, Deals By Region, 2012 to YTD 2018 7

SeraCare Life Sciences, Inc., Deals By Market, 2012 to YTD 2018 8

SeraCare Life Sciences, Inc., Medical Equipment, Deals Summary, 2012 to YTD 2018 9

SeraCare Receives Shareholders Approval For Its Acquisition By Linden Capital For USD 82 Million 10

SeraCare Life Sciences Enters into Agreement with ArcherDx 12

SeraCare Life Sciences Enters into R&D Agreement with National Institute of Standards and Technology 13

SeraCare Life Sciences Forms Partnership with Toma Biosciences 14

Swift Biosciences Partners with SeraCare Life Sciences 15

SeraCare Life Sciences Enters into Co-Marketing Agreement with ViveBio 16

SeraCare Life Sciences Enters into R&D Agreement with National Cancer Institute 17

SeraCare Life Sciences Acquires Kirkegaard & Perry Labs 18

SeraCare Life Sciences, Inc., Key Competitors 19

SeraCare Life Sciences, Inc., Key Employees 20

SeraCare Life Sciences, Inc., Other Locations 21

SeraCare Life Sciences, Inc., Subsidiaries 21

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

SeraCare Life Sciences, Inc., Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.